Vytrus Biotech S.A. (VYT) — Cash Flow Quality Index
Vytrus Biotech S.A. (VYT) has a Cash Flow Quality Index of 0.50x as of December 2022. Operating cash flow of €225.55K is below net income of €452.79K, suggesting accrual-heavy earnings not yet converted to cash. Explore Vytrus Biotech S.A. cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vytrus Biotech S.A. Cash Flow Quality Index (2020–2025)
Historical Cash Flow Quality Index for Vytrus Biotech S.A. across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check VYT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Vytrus Biotech S.A. (2020–2025)
Year-by-year earnings quality comparison for Vytrus Biotech S.A.. For live market cap and the full company financial profile, see VYT market cap overview.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▲ +233.2% |
| 2022 | 0.50x | €225.55K | €452.79K | ▼ -65.6% |
| 2021 | 1.45x | €447.92K | €309.17K | ▲ +200.2% |
| 2020 | -1.45x | €-132.47K | €91.60K | — |